Skip to content

Research on the Application of Neuroelectrophysiological Monitoring Techniques in Prognosis Assessment for Brain Tumor Patients

Research on the Application of Neuroelectrophysiological Monitoring Techniques in Prognosis Assessment for Brain Tumor Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126852
Enrollment
Unknown
Registered
2026-06-17
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary or metastatic intracranial tumors

Interventions

Monitoring negative group (No predefined significant alert events have occurred):None
Monitoring positive group (The amplitude of the motor evoked potential decreases by more than 50%, the amplitude of the somatosensory evoked potential decreases by more than 50%):None

Sponsors

Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital;
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with intracranial primary or metastatic tumors via imaging (MRI) and postoperative pathology. 2. Age range of 18-75 years. 3. Tumors located in or adjacent to critical functional pathways such as the motor cortex, sensory cortex, language areas, or pyramidal tract. 4. Scheduled for microscopic tumor resection with intraoperative neurophysiological monitoring. 5. Informed consent obtained from the patient or family members, with a signed consent form. 6. Subjects are stratified based on "whether significant warning events occurred during neurophysiological monitoring": those with positive monitoring results are assigned to the positive group, while those with negative monitoring results are assigned to the negative group.

Exclusion criteria

Exclusion criteria: 1. Those who have severe neurological deficits (such as mRS score >3) before surgery and are unable to cooperate in completing basic electrophysiological testing and functional evaluation; 2. Individuals with severe systemic diseases such as heart, lung, liver, and kidney dysfunction, coagulation dysfunction, etc.; 3. History of status epilepticus or presence of metal implants such as pacemakers or deep brain stimulators in the body (affecting monitoring safety); 4. Pregnant or lactating women; 5. Those who are unable to complete postoperative follow-up.

Design outcomes

Primary

MeasureTime frame
Neuroelectrophysiological indicators: motor evoked potential (MEP), somatosensory evoked potential (SEP), intraoperative direct electrical stimulation mapping (DCS Mapping), electroencephalogram (cEEG;

Secondary

MeasureTime frame
Neurological function deficit score (NIHSS);Ability to perform daily activities (Barthel Index);

Countries

China

Contacts

Public ContactYuan Li

Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital;

2721693606@qq.com+86 763 6411008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026